Arm CEO cites chip supply constraints in AI medical research

The chief executive of Arm stated that current shortages in high-performance computing chips are hindering efforts to model DNA markers in cancer research. While the company remains optimistic that advanced computing will eventually solve complex biological problems, the lack of available hardware is currently slowing progress. The ability to simulate how specific DNA markers react to cancer is dependent on significant processing power that is not currently accessible at the required scale. Monitor future supply chain updates regarding high-end chip availability for research and development sectors.